Pulse Biosciences's three largest insider shareholders as of March 23, 2026 are Mahkam Zanganeh (Director, 725.39K shares), Darrin Uecker (Chief Technology Officer, 284.41K shares), Mitchell E. Levinson (Chief Strategy Officer, 102.40K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Mahkam Zanganeh | 725,395 | 0 | 11 Feb, 2025 | |
| Darrin Uecker | Chief Technology Officer | 284,406 | 0 | 18 Sep, 2025 |
| Mitchell E. Levinson | Chief Strategy Officer | 93,880 | 8,521 | 30 Sep, 2024 |
| Burke Thomas Barrett | 63,172 | 0 | 20 Dec, 2024 | |
| Kevin Patrick Danahy | Chief Commercial Officer | 43,298 | 0 | 23 Feb, 2026 |
| Ed Ebbers | Evp Gm, Dermatology | 39,300 | 0 | 03 Jun, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 5,000 | $1.53 | 48,298 | D | M |
| 18 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 5,000 | $23.64 | 43,298 | D | S |
| 18 Feb, 2026 | Kevin Patrick Danahy | Stock Option (right to buy) | D | 5,000 | $0.00 | 300,000 | D | M |
| 12 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 12 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $23.37 | 43,298 | D | S |
| 13 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 13 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $23.53 | 43,298 | D | S |
| 17 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 17 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $23.63 | 43,298 | D | S |
| 12 Feb, 2026 | Kevin Patrick Danahy | Stock Option (right to buy) | D | 20,000 | $0.00 | 345,000 | D | M |
| 13 Feb, 2026 | Kevin Patrick Danahy | Stock Option (right to buy) | D | 20,000 | $0.00 | 325,000 | D | M |
| 17 Feb, 2026 | Kevin Patrick Danahy | Stock Option (right to buy) | D | 20,000 | $0.00 | 305,000 | D | M |
| 09 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 09 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $21.45 | 43,298 | D | S |
| 10 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 10 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $23.52 | 43,298 | D | S |
| 11 Feb, 2026 | Kevin Patrick Danahy | Common Stock | A | 20,000 | $1.53 | 63,298 | D | M |
| 11 Feb, 2026 | Kevin Patrick Danahy | Common Stock | D | 20,000 | $25.20 | 43,298 | D | S |
| 09 Feb, 2026 | Kevin Patrick Danahy | Stock Option (right to buy) | D | 20,000 | $0.00 | 405,000 | D | M |
| 10 Feb, 2026 | Kevin Patrick Danahy | Stock Option (right to buy) | D | 20,000 | $0.00 | 385,000 | D | M |